Vainio, A, Auvinen, A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage. 1996;12(1):3–10.CrossRefGoogle Scholar

Krech, RL, Walsh, D. Symptoms of pancreatic cancer. J Pain Symptom Manage. 1991;6(6):360–367.CrossRefGoogle ScholarPubMed

Brescia, FJ, Adler, D, Gray, G. Hospitalized advanced cancer patients: a profile. J Pain Symptom Manage. 1990;5(4):221–227.CrossRefGoogle ScholarPubMed

Coyle, N, Adelhardt, J, Foley, KM. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990;5(2):83–93.CrossRefGoogle ScholarPubMed

Higginson, I, McCarthy, M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med. 1989;82(5):264–267.CrossRefGoogle ScholarPubMed

Reuben, DB, Mor, V, Hiris, J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988;148(7):1586–1591.CrossRefGoogle ScholarPubMed

Reuben, DB, Mor, V. Dyspnea in terminally ill cancer patients. Chest. 1986;89(2):234–236.CrossRefGoogle ScholarPubMed

Dudgeon, DJ, Kristjanson, L, Sloan, JA. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage. 2001;21(2):95–102.CrossRefGoogle ScholarPubMed

Currow, DC, Plummer, JL, Crockett, A. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage. 2009:38(4):533–545.CrossRefGoogle ScholarPubMed

Salminen, E, Clemens, KE, Syrjanen, K. Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland. Supportive Care Cancer. 2008;16(1):3–8.CrossRefGoogle ScholarPubMed

Tsai, J-S, Wu, C-H, Chiu, T-Y. Symptom patterns of advanced cancer patients in a palliative care unit. Palliative Med. 2006;20(6):617–622.CrossRefGoogle Scholar

Chiu, T-Y, Hu, W-Y, Lue, B-H. Dyspnea and its correlates in Taiwanese patients with terminal cancer. J Pain Symptom Manage. 2004;28(2):123–132.CrossRefGoogle ScholarPubMed

Mercadante, S, Casuccio, A, Fulfaro, F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage. 2000;20(2):104–112.CrossRefGoogle ScholarPubMed

Bruera, E, Schoeller, T, MacEachern, T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage. 1992;7(6):365–368.CrossRefGoogle Scholar

Dudgeon, DJ. Managing dyspnea and cough. Hematol Oncol Clin N Am. 2002;16(3):557–577.CrossRefGoogle ScholarPubMed

Dudgeon, DJ, Lertzman, M, Dudgeon, DJ. Dyspnea in the advanced cancer patient. J Pain Symptom Manage. 1998;16(4):212–219.CrossRefGoogle ScholarPubMed

Tanaka, K, Akechi, T, Okuyama, T. Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer. 2000;82(4): 800–805.CrossRefGoogle ScholarPubMed

Edmonds, P, Higginson, I, Altmann, D. Is the presence of dyspnea a risk factor for morbidity in cancer patients? J Pain Symptom Manage. 2000;19(1):15–22.CrossRefGoogle ScholarPubMed

,Dyspnea: mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159(1):321–340.Google Scholar

Luce, JM, Luce, JA, Luce, JM. Perspectives on care at the close of life: management of dyspnea in patients with far-advanced lung disease: “once I lose it, it's kind of hard to catch it.…”J Am Med Assoc. 2001;285(10):1331–1337.CrossRefGoogle Scholar

Cristiano, LM, Schwartzstein, RM, Cristiano, LM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155(5):1552–1559.CrossRefGoogle ScholarPubMed

O';Donnell, , Webb, KA, O';Donnell, . Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis. 1993;148(5):1351–1357.CrossRefGoogle Scholar

Nishino, T, Ide, T, Sudo, T. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med. 2000;161(6):1963–1967.CrossRefGoogle ScholarPubMed

Ferrell, BA. Pain evaluation and management in the nursing home. Ann Intern Med. 1995;123(9):681–687.CrossRefGoogle ScholarPubMed

Rao, AV, Hsieh, F, Feussner, JR. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol. 2005;60(6):798–803.CrossRefGoogle ScholarPubMed

Papiris, SA, Daniil, ZD, Malagari, K. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med. 2005;99(6):755–761.CrossRefGoogle ScholarPubMed

Uronis, HE, Blackwell, S, Bosworth, H. An examination of the psychometric properties of an English version of the Cancer Dyspnea Scale (CDS) for evaluating dyspnea in patients with advanced lung cancer. Support Care Cancer. 2007;15:728.Google Scholar

Hardy, JR, Turner, R, Saunders, M. Prediction of survival in a hospital-based continuing care unit. Eur J Cancer. 1994;30A(3):284–288.CrossRefGoogle Scholar

Chang, VT, Thaler, HT, Polyak, TA. Quality of life and survival: the role of multidimensional symptom assessment. Cancer. 1998;83(1):173–179.3.0.CO;2-T>CrossRefGoogle ScholarPubMed

Abernethy, AP, Currow, DC, Frith, P. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea [see comment]. Br Med J. 2003;327(7414):523–528.CrossRefGoogle Scholar

Currow, DC, Abernethy, AP, Frith, P. Morphine for management of refractory dyspnea. Br Med J. 2003;327:1288–1289.CrossRefGoogle Scholar

Pauwels, RA, Buist, AS, Calverley, PM. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276.CrossRefGoogle ScholarPubMed

Leach, RM.Palliative medicine and non-malignant, end-stage respiratory disease. In: Doyle, D, Hanks, G, Cherny, N, eds. Oxford Textbook of Palliative Medicine. 3rd ed. New York: Oxford University Press; 2005:895–916.Google Scholar

Eckenhoff, JE, Oech, SR. The effects of narcotics and antagonists upon respiration and circulation in man: a review. Clin Pharmacol Ther. 1960;1:483–524.Google Scholar

Santiago, TV, Pugliese, AC, Edelman, NH. Control of breathing during methadone addiction. Am J Med. 1977;62(3):347–354.CrossRefGoogle ScholarPubMed

Weil, JV, McCullough, RE, Kline, JS. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med. 1975;292(21):1103–1106.CrossRefGoogle ScholarPubMed

Kryger, MH, Yacoub, O, Dosman, J. Effect of meperidine on occlusion pressure responses to hypercapnia and hypoxia with and without external inspiratory resistance. Am Rev Respir Dis. 1976;114(2):333–340.Google ScholarPubMed

Santiago, TV, Johnson, J, Riley, DJ. Effects of morphine on ventilatory response to exercise. J Appl Physiol. 1979;47(1):112–118.CrossRefGoogle ScholarPubMed

Jennings, AL, Davies, AN, Higgins, JP. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939–944.CrossRefGoogle ScholarPubMed

Bruera, E, MacEachern, T, Ripamonti, C. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 1993;119(9):906–907.CrossRefGoogle ScholarPubMed

Mazzocato, C, Buclin, T, Rapin, CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 1999;10(12):1511–1514.CrossRefGoogle ScholarPubMed

Buck, C, Laier-Groeneveld, G, Criee, CP. The effect of dihydrocodeine and terbutaline on breathlessness and inspiratory muscle function in normal subjects and patients with COPD [abstract]. Eur Respir J. 1996;9:344S.Google Scholar

Chua, TP, Harrington, D, Ponikowski, P. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 1997;29(1):147–152.CrossRefGoogle ScholarPubMed

Johnson, MA, Woodcock, AA, Geddes, DM. Dihydrocodeine for breathlessness in “pink puffers.” Br Med J Clin Res Ed. 1983;286(6366):675–677.CrossRefGoogle ScholarPubMed

Woodcock, AA, Gross, ER, Gellert, A. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981;305(27):1611–1616.CrossRefGoogle ScholarPubMed

Viola, R, Kiteley, C, Lloyd, NS. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer. 2008;16(4):329–337.CrossRefGoogle ScholarPubMed

Booth, S, Anderson, H, Swannick, M. The use of oxygen in the palliation of breathlessness: a report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004;98(1): 66–77.CrossRefGoogle Scholar

Uronis, HE, Currow, DC, McCrory, DC. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008;98(2):294–299.CrossRefGoogle ScholarPubMed

Guyatt, GH, McKim, DA, Austin, P. Appropriateness of domiciliary oxygen delivery. Chest. 2000;118(5):1303–1308.CrossRefGoogle ScholarPubMed

Abernethy, AP, Currow, DC, Frith, PA. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliative Med. 2005;19:165–172.CrossRefGoogle ScholarPubMed

Stringer, E, McParland, C, Hernandez, P. Physician practices for prescribing supplemental oxygen in the palliative care setting. J Palliative Care. 2004;20(4):303–307.Google ScholarPubMed

Abernethy, AP, McDonald, C, Frith, P. Palliative oxygen versus medical air for relief of dyspnea: results of an international, multi-site, randomized controlled trial. Paper presented at: Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association; March 27, 2009; Austin, TX.

Currow, DC, Fazekas, B, Abernethy, AP. Oxygen use – patients define symptomatic benefit discerningly. J Pain Symptom Manage. 2007;34(2):113–114.CrossRefGoogle ScholarPubMed

Kim, HF, Kunik, ME, Molinari, VA. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–471.CrossRefGoogle ScholarPubMed

Mitchell-Heggs, P, Murphy, K, Minty, K. Diazepam in the treatment of dyspnoea in the “Pink Puffer” syndrome. Q J Med. 1980;49(193):9–20.Google ScholarPubMed

Sen, D, Jones, G, Leggat, PO. The response of the breathless patient treated with diazepam. Br J Clin Pract. 1983;37(6):232–233.Google ScholarPubMed

Woodcock, AA, Gross, ER, Geddes, DM. Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J Clin Res Ed. 1981;283(6287): 343–346.CrossRefGoogle ScholarPubMed

Navigante, AH, Cerchietti, LC, Castro, MA. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006;31(1):38–47.CrossRefGoogle ScholarPubMed

Man, GC, Hsu, K, Sproule, BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest. 1986;90(6):832–836.CrossRefGoogle ScholarPubMed

Eimer, M, Cable, T, Gal, P. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction. J Fam Pract. 1985;21(5):359–362.Google ScholarPubMed

Garner, SJ, Eldridge, FL, Wagner, PG. Buspirone, an anxiolytic drug that stimulates respiration. Am Rev Respir Dis. 1989;139(4):946–950.CrossRefGoogle ScholarPubMed

Mendelson, WB, Martin, JV, Rapoport, DM. Effects of buspirone on sleep and respiration. Am Rev Respir Dis. 1990;141(6):1527–1530.CrossRefGoogle ScholarPubMed

Argyropoulou, P, Patakas, D, Koukou, A. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration. 1993;60(4):216–220.CrossRefGoogle ScholarPubMed

Singh, NP, Despars, JA, Stansbury, DW. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest. 1993;103(3):800–804.CrossRefGoogle ScholarPubMed

Burns, BH, Howell, JB. Disproportionately severe breathlessness in chronic bronchitis. Q J Med. 1969;38(151):277–294.Google ScholarPubMed

Mueller, RA, Lundberg, DB, Breese, GR. The neuropharmacology of respiratory control. Pharmacol Rev. 1982;34(3):255–285.Google ScholarPubMed

Papp, , Weiss, JR, Greenberg, HE. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry. 1995;152(10):1531.Google ScholarPubMed

Smoller, JW, Pollack, MH, Systrom, D. Sertraline effects on dyspnea in patients with obstructive airway disease. Psychosomatics. 1998;39(1):24–29.CrossRefGoogle Scholar

Ventresca, PG, Nichol, GM, Barnes, PJ. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis. 1990;142(1):143–146.CrossRefGoogle Scholar

Bianco, S, Pieroni, MG, Refini, RM. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med. 1989;321(16):1069–1073.CrossRefGoogle ScholarPubMed

Bianco, S, Vaghi, A, Robuschi, M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet. 1988;2(8605): 252–255.CrossRefGoogle ScholarPubMed

Robuschi, M, Gambaro, G, Spagnotto, S. Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulm Pharmacol. 1989;1(4): 187–191.CrossRefGoogle ScholarPubMed

Chung, KF, Barnes, PJ. Loop diuretics and asthma. Pulm Pharmacol. 1992;5(1):1–7.CrossRefGoogle ScholarPubMed

Ong, K-C, Kor, A-C, Chong, W-F. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(9):1028–1033.CrossRefGoogle ScholarPubMed

Ahmedzai, SH, Laude, E, Robertson, A. A double-blind, randomised, controlled phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. Br J Cancer. 2004;90(2):366–371.CrossRefGoogle ScholarPubMed

Corner, J, O';Driscoll, M. Development of a breathlessness assessment guide for use in palliative care. Palliative Med. 1999;13(5):375–384.CrossRefGoogle ScholarPubMed

O';Neill, S, McCarthy, DS. Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax. 1983;38(8):595–600.CrossRefGoogle Scholar

Sharp, JT, Drutz, WS, Moisan, T. Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980;122(2):201–211.Google ScholarPubMed

Barach, AL.Chronic obstructive lung disease: postural relief of dyspnea. Arch Phys Med Rehab. 1974;55(11):494–504.Google ScholarPubMed

Barach, AL, Beck, GJ. The ventilatory effects of the head-down position in pulmonary emphysema. Am J Med. 1954;16(1):55–60.CrossRefGoogle ScholarPubMed

Tiep, BL, Burns, M, Kao, D. Pursed lips breathing training using ear oximetry. Chest. 1986;90(2):218–221.CrossRefGoogle ScholarPubMed

Madge, S, Edmond, G. End-stage management of respiratory disease. In: Esmond, G, ed. Respiratory Nursing. London: Bailliere Tindall; 2001: 229–240.Google Scholar

Smith, EL, Hann, DM, Ahles, TA. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage. 2001;21(4):323–329.CrossRefGoogle ScholarPubMed

Booth, S, Silvester, S, Todd, C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliative Support Care. 2003;1(4):337–344.CrossRefGoogle ScholarPubMed

Seamark, DA, Blake, SD, Seamark, CJ. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliative Med. 2004;18(7):619–625.CrossRefGoogle ScholarPubMed

Saunders, C. Care of patients suffering from terminal illness at St. Joseph's Hospice, Hackney, London. Nursing Mirror. 1964;14:vii–x.Google Scholar

Abernethy, AP, Wheeler, JL. Total dyspnoea. Curr Opin Support Palliative Care. 2008;2(2):110–113.CrossRefGoogle ScholarPubMed

Zigmond, AS, Snaith, RP, Zigmond, AS. The Hospital Anxiety and Depression Scale. Acta Psych Scand. 1983;67(6):361–370.CrossRefGoogle ScholarPubMed

NCCN Clinical Practice Guidelines in Oncology: Distress Management. Fort Washington, PA: National Comprehensive Cancer Network; 2007.

Peterman, AH, Fitchett, G, Brady, MJ. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy – Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24(1):49–58.CrossRefGoogle Scholar

,VNAA Chronic Care Clearinghouse home page. Available at: http://www.chronicconditions.org/.

,Pulmonary Rehabilitation Toolkit home page. Available at: http://www.pulmonaryrehab.com.au/.

Bruera, E, MacEachern, T, Ripamonti, C. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 1993;119(9):906–907.CrossRefGoogle ScholarPubMed